Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.

Viking begins phase III VANQUISH program for VK2735, targeting weight loss in obese adults with or without type II diabetes.

Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...